ABSTRACT
In humans, skin barrier dysfunction is thought to be responsible for enhanced penetration of allergens. Similar to conditions seen in humans, canine atopic dermatitis (CAD) is characterized by derangement of corneocytes and disorganization of intercellular lipids in the stratum corenum (SC) with decreased ceramide levels. This study was designed to evaluate the effects of a moisturizer containing ceramide on dogs with CAD. Dogs (n = 20, 3~8 years old) with mild to moderate clinical signs were recruited and applied a moisturizer containing ceramide for 4 weeks. Transepidermal water loss (TEWL), skin hydration, pruritus index for canine atopic dermatitis (PICAD) scores, and canine atopic dermatitis extent and severity index (CADESI) scores of all dogs were evaluated. Skin samples from five dogs were also examined with transmission electron microscopy (TEM) using ruthenium tetroxide. TEWL, PICAD, and CADESI values decreased (p < 0.05) and skin hydration increased dramatically over time (p < 0.05). Electron micrographs showed that the skin barrier of all five dogs was partially restored (p < 0.05). In conclusion, these results demonstrated that moisturizer containing ceramide was effective for treating skin barrier dysfunction and CAD symptoms.
Subject(s)
Ceramides/therapeutic use , Cholesterol/therapeutic use , Dermatitis, Atopic/veterinary , Dog Diseases/drug therapy , Emollients/therapeutic use , Fatty Acids, Nonesterified/therapeutic use , Animals , Dermatitis, Atopic/complications , Dermatitis, Atopic/drug therapy , Dermatitis, Atopic/physiopathology , Dog Diseases/etiology , Dog Diseases/physiopathology , Dogs , Epidermis/drug effects , Epidermis/physiopathology , Epidermis/ultrastructure , Female , Male , Microscopy, Electron, Transmission/veterinary , Pruritus/drug therapy , Pruritus/etiology , Pruritus/physiopathology , Pruritus/veterinary , Republic of Korea , Ruthenium Compounds/chemistry , Water Loss, Insensible/drug effectsABSTRACT
BACKGROUND: Staphylococcus pseudintermedius is a common pathogen of skin and ear infections in dogs. The widespread and rapid emergence of meticillin-resistant S. pseudintermedius (MRSP) has created therapeutic challenges in veterinary medicine and the need for alternative treatments. HYPOTHESIS/OBJECTIVES: We aimed to evaluate the in vitro antimicrobial activity of the essential oil manuka (Leptospermum scoparium) against S. pseudintermedius. METHODS: This study was performed using S. pseudintermedius strains isolated from dogs with skin and ear infections collected throughout Korea between 2009 and 2011. The in vitro antimicrobial activity of manuka oil against 39 MRSP and 11 meticillin-susceptible S. pseudintermedius (MSSP) strains was analysed by measuring minimal inhibitory concentrations (MICs) using the agar dilution method and biofilm inhibition activity as assessed by the colorimetric microtitre plate assay. RESULTS: Our results indicated that manuka oil had excellent activity against all bacterial isolates. The MICs for MRSP and MSSP to manuka oil were in the range of 2(-9) to 2(-6) and 2(-9) to 2(-7) % (v/v), respectively. Manuka oil was a potent inhibitor of S. pseudintermedius biofilm formation, and the majority of bacteria decreased by >50%. No significant differences were observed in the MICs or biofilm formation between the MRSP and MSSP strains. CONCLUSIONS AND CLINICAL IMPORTANCE: These results suggest that manuka oil has the potential to be a useful therapeutic option for treating superficial infections caused by MRSP and MSSP; further clinical investigations are required.
Subject(s)
Biofilms/growth & development , Dog Diseases/microbiology , Leptospermum/chemistry , Plant Oils/pharmacology , Staphylococcus/drug effects , Staphylococcus/isolation & purification , Animals , Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Dogs , Methicillin/pharmacology , Methicillin Resistance , Microbial Sensitivity Tests , Plant Oils/chemistry , Republic of Korea/epidemiology , Skin Diseases, Bacterial/epidemiology , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/veterinary , Staphylococcus/classification , Staphylococcus/physiologyABSTRACT
The aim of this study was to investigate the characteristics of canine uropathogenic Escherichia coli (UPEC) and the interaction between canine UPEC and human bladder epithelial cells. Ten E. coli isolates collected from dogs with cystitis were analyzed for antimicrobial resistance patterns, the presence of virulence factors, and biofilm formation. The ability of these isolates to induce cytotoxicity, invade human bladder epithelial cells, and stimulate an immune response was also determined. We observed a high rate of antimicrobial resistance among canine UPEC isolates. All virulence genes tested (including adhesins, iron acquisition, and protectin), except toxin genes, were detected among the canine UPEC isolates. We found that all isolates showed varying degrees of biofilm formation (mean, 0.26; range, 0.07 to 0.82), using a microtiter plate assay to evaluate biofilm formation by the isolates. Cytotoxicity to human bladder epithelial cells by the canine UPEC isolates increased in a time-dependent manner, with a 56.9% and 36.1% reduction in cell viability compared with the control at 6 and 9 h of incubation, respectively. We found that most canine UPEC isolates were able to invade human bladder epithelial cells. The interaction between these isolates and human bladder epithelial cells strongly induced the production of proinflammatory cytokines such as IL-6 and IL-8. We demonstrated that canine UPEC isolates can interact with human bladder epithelial cells, although the detailed mechanisms remain unknown. The results suggest that canine UPEC isolates, rather than dogspecific pathogens, have zoonotic potential.
Subject(s)
Dog Diseases/microbiology , Epithelial Cells/microbiology , Escherichia coli Infections/veterinary , Urinary Tract Infections/veterinary , Uropathogenic Escherichia coli/isolation & purification , Zoonoses/microbiology , Animals , Anti-Bacterial Agents/pharmacology , Biofilms/growth & development , Cell Survival , Cells, Cultured , Cytokines/metabolism , Dog Diseases/transmission , Dogs , Escherichia coli Infections/microbiology , Escherichia coli Infections/transmission , Humans , Microbial Sensitivity Tests , Urinary Tract Infections/microbiology , Urinary Tract Infections/transmission , Uropathogenic Escherichia coli/drug effects , Uropathogenic Escherichia coli/pathogenicity , Uropathogenic Escherichia coli/physiology , Virulence Factors/geneticsABSTRACT
We investigated Malassezia species and genotypes colonizing dogs, comparing those recovered from the ear canal with those from other anatomical body sites, as well as from diseased and healthy skin. The Malassezia isolates were obtained from four types of skin samples, i.e., diseased ear, diseased skin, healthy ear, and healthy skin. Sequences of the 26S ribosomal DNA region, the intergenic spacer 1 (IGS-1) and the internal transcribed spacer 1 (ITS-1) DNA region were analyzed. These confirmed the presence of Malassezia pachydermatis, which could be separated into three main sequence genotype groups (A, B, C). Genotype A was the most common, only two genotype B isolates were recovered from diseased skin lesion and genotype C was more likely to be isolated from ear samples than from other healthy or diseased-skin sites. The present findings provide the basis for further studies of genotypic diversity in M. pachydermatis, as well as their pathogenic potential.
Subject(s)
Dermatomycoses/veterinary , Dog Diseases/microbiology , Genetic Variation , Malassezia/isolation & purification , Animals , Base Sequence , DNA, Fungal/chemistry , DNA, Fungal/genetics , DNA, Intergenic/chemistry , DNA, Intergenic/genetics , DNA, Ribosomal Spacer/chemistry , DNA, Ribosomal Spacer/genetics , Dermatomycoses/microbiology , Dogs , Ear Canal/microbiology , Female , Genotype , Malassezia/classification , Malassezia/genetics , Male , Molecular Sequence Data , Phylogeny , Republic of Korea/epidemiology , Sebum , Sequence Alignment/veterinary , Sequence Analysis, DNA/veterinary , Skin/microbiologyABSTRACT
The purpose of this study was to evaluate the effects of a topical spray containing 0.0584% hydrocortisone aceponate (HCA) on canine atopic dermatitis (CAD) and to evaluate the skin barrier function during the treatment of CAD. Twenty-one dogs that fulfilled the diagnostic criteria for CAD were included in this study. The HCA spray was applied once a day to the lesions of all dogs for 7 or 14 days. Clinical assessment was performed before (day 0) and after treatment (day 14), and clinical responses were correlated with changes in skin barrier function. CAD severity significantly decreased after 14 days of HCA treatment based on the lesion scores (p < 0.0001), which were determined using the CAD extent and severity index (CADESI-03) and pruritus scores (p < 0.0001) calculated using a pruritus visual analog scale. Transepidermal water loss, a biomarker of skin barrier function, was significantly reduced compared to baseline (day 0) measurements (p = 0.0011). HCA spray was shown to be effective for significantly improving the condition of dogs suffering from CAD. This treatment also significantly improved cut.